Agios Pharmaceuticals reported $0 in Ordinary Share Capital for its second fiscal quarter of 2020.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Alnylam Pharmaceuticals ALNY:US $ 1.16M 0M
Amgen AMGN:US $ 31610M 85M
AstraZeneca AZN:LN 328M 0M
Bayer BAYN:GR € 2515M 0M
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bluebird Bio BLUE:US $ 0.66M 0.11M
Bristol Myers Squibb BMY:US $ 292M 0M
Daiichi Sankyo 4568:JP Y 50000M 0M
Eli Lilly And LLY:US $ 598.1M 0M
Gilead Sciences GILD:US $ 1M 0M
GlaxoSmithKline GSK:LN 1346M 0M
Immunogen IMGN:US $ 1.75M 0M
JAZZ PHA JAZZ:US $ 0.06M 0M
Merk MRK:US $ 1788M 0M
Novartis NVS:US $ 913M 0M
Pfizer PFE:US $ 470M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
Vertex Pharmaceuticals VRTX:US $ 2.6M 0.01M
YTE INCY:US $ 0.22M 0M